Supplementary Figure S1

Slides:



Advertisements
Similar presentations
Isotype control Supplementary Figure S1. Strategy for gating CD11b+CD14-CD33+CD40+ myeloid cells. Singlets were gated from live cells shown in forward.
Advertisements

Supplementary Figures NormalCRC CRC+5FU CRC+CPT11 100µm S1.
Supplementary Figures and Figure Captions
Figure S1. A B C Survival probability (%) P = 0.21 P = 0.37 P = 0.12
Supplementary Figure 1 Supplementary Figure 1: ROR agonists increase the expression of a luciferase reporter driven by Gal4-ROR. In HEK293T cells, Gal4-ROR
Flow cytometry plot gated on human CD4 T cells
500 mg total protein /mL S-CM 250 mg total protein /mL S-CM
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β- Defensins via Induction of Regulatory T Cells  Anika Bruhs, Thomas.
Volume 61, Issue 2, Pages (February 2012)
Volume 43, Issue 1, Pages (July 2015)
Transforming Growth Factor-β Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development  Weiming Ouyang, Omar Beckett, Qian Ma,
Host-Derived Interleukin-18 Differentially Impacts Regulatory and Conventional T Cell Expansion During Acute Graft-Versus-Host Disease  Robert Zeiser,
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Volume 141, Issue 3, Pages (September 2011)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 81, Issue 9, Pages (May 2012)
Volume 76, Issue 7, Pages (October 2009)
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)  Aleena.
Markers of cancer cell and lymphocytes in inflammatory infiltration around a tumour as potential markers of immunomodulatory treatment response. Markers.
Volume 140, Issue 7, Pages (June 2011)
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Supplementary figures
Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760)  Koji Kurose, MD, Yoshihiro.
CCR10 regulates balanced maintenance and function of resident regulatory and effector T cells to promote immune homeostasis in the skin  Mingcan Xia,
Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation 
A B C D E F Supplementary Fig. 2. Gating strategy for CD44+CD24+ ID8agg tumor initiating cells (TIC). Cells were gated on CD44. CD44 positive cells were.
IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis  Stéphanie.
Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3–positive regulatory versus TH2 effector cells to.
Volume 42, Issue 3, Pages (March 2015)
Targeting PKC in Human T Cells Using Sotrastaurin (AEB071) Preserves Regulatory T Cells and Prevents IL-17 Production  Xuehui He, Hans J.P.M. Koenen,
Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760)  Koji Kurose, MD, Yoshihiro.
Loss of pathogen-specific T cell memory is due to the absence of Runx2 in CD8+ T cells. Loss of pathogen-specific T cell memory is due to the absence of.
Peptide ID# Pulsed to T2-A24 Cells
Volume 34, Issue 3, Pages (March 2011)
Allospecific Tregs Expanded After Anergization Remain Suppressive in Inflammatory Conditions but Lack Expression of Gut-homing Molecules  Eleni Kotsiou,
Immunologic Resolution of Human Chronic Graft-versus-Host Disease
Alvin W. L. Schadenberg, MD, Theo van den Broek, MD, Marten A
Volume 34, Issue 4, Pages (April 2011)
Effector T cells (Th-) Regulatory T cells Treg Th17 Th1 Th2
Volume 28, Issue 6, Pages (June 2008)
Fig. 4. Analysis of T cell responses according to treatment and in peptide-treated C-peptide responders and nonresponders. Analysis of T cell responses.
IL-33 treatment improves restorative macrophages (MΦ) but not function
Volume 30, Issue 6, Pages (June 2009)
Volume 36, Issue 2, Pages (February 2012)
Volume 43, Issue 5, Pages (November 2015)
Volume 43, Issue 6, Pages (December 2015)
FOXP3+CD25− Tumor Cells with Regulatory Function in Sézary Syndrome
Volume 27, Issue 4, Pages e4 (April 2019)
Volume 43, Issue 2, Pages (August 2015)
PD-1–PD-L1 axis is highly expressed and is not IFNγ-dependent in a subcutaneous murine model of PDA. A, experimental design for establishment of subcutaneous.
Volume 10, Issue 1, Pages (July 2011)
IL-6 neutralization results in induction of CD161+ FOXP3+ CD127– Tregs in EC–CD4+ T cell cocultures. IL-6 neutralization results in induction of CD161+
High-dimensional analysis of effector CD4 T cell function following γHV68 infection in B6 and IL-10KO mice. High-dimensional analysis of effector CD4 T.
Foxp3+ Regulatory T Cells of Psoriasis Patients Easily Differentiate into IL-17A- Producing Cells and Are Found in Lesional Skin  H. Jorn Bovenschen, Peter.
PD-1 blockade enhances T-cell function.
Human Treg Classes Balance Immunosuppression
Meet the Ikaros Family IL-2 Helios CD103 GITR Naïve CD4+ T cell
Yunqi Wang, Maureen A. Su, Yisong Y. Wan  Immunity 
CD4+CLA+CD103+ T cells constitute a unique cell population in human blood. CD4+CLA+CD103+ T cells constitute a unique cell population in human blood. (A)
The TSDR of ATL cells exhibits Treg-like hypomethylated status or CD4+ conventional T cell–like methylated status. The TSDR of ATL cells exhibits Treg-like.
A Role for Regulatory T Cells in Cutaneous T-Cell Lymphoma; Induction of a CD4+CD25+Foxp3+ T-Cell Phenotype Associated with HTLV-1 Infection  Patrick.
Volume 142, Issue 7, Pages e6 (June 2012)
Figure 1. Cross talk between the immune system and osteoclasts in osteoclastogenesis. Osteoclasts are derived from monocyte precursor cells. RANKL from.
Roles of CD28, CTLA4, and Inducible Costimulator in Acute Graft-versus-Host Disease in Mice  Jun Li, Kenrick Semple, Woong-Kyung Suh, Chen Liu, Fangping.
Genetic Targeting of the Active Transcription Factor XBP1s to Dendritic Cells Potentiates Vaccine-induced Prophylactic and Therapeutic Antitumor Immunity 
Volume 39, Issue 5, Pages (November 2013)
Volume 24, Issue 6, Pages e6 (August 2018)
IL-9–expressing TH cells are highly enriched in CCR4+/CCR8+ effector memory TH cells. IL-9–expressing THcells are highly enriched in CCR4+/CCR8+effector.
IL2Cx alone or in combination with anti–CTLA-4 increases the CD8/Treg ratio in the tumor. IL2Cx alone or in combination with anti–CTLA-4 increases the.
FIGURE 1 WT CD2 TG CD25 CONTROL IL-2 CD3/CD28 CD3/CD28+IL
Presentation transcript:

Supplementary Figure S1 ATL cells CD4 CD7 CD25 CD3 CD5 CD4 Include normal Tregs CD7 CD25 CD5 CD4

Supplementary Figure S2 A B Methylation status of CTLA4 exon 2 Methylation status of HELIOS intron 5. Healthy donor CD4+CD25- conventional T cells Healthy donor CD4+CD25- conventional T cells Healthy donor Regulatory T cells Healthy donor Regulatory T cells Primary ATL cells Primary ATL cells 1 16 1 16 2 17 2 17 3 18 3 18 4 19 4 19 5 20 5 20 6 21 6 21 7 22 7 22 8 23 8 23 9 24 9 24 Not available 10 25 10 25 11 26 11 26 12 12 13 13 14 14 15 15 HTLV-1-infected cell lines HTLV-1-infected cell lines MT-1 MT-1 MJ MJ MT-2 MT-2 ATL-43T ATL-43T MT-4 MT-4 Hut102 Hut102 CpG demethylation 0% 100%

Supplementary Figure S3 A Hypomethylation Methylation ATL cells MJ Hut102 Isotype 100 99.7% 24.2% Cell Numbers (% Max) MFI =17401 MFI =328 FOXP3 100 20000 80 15000 60 % of FOXP3+ cells MFI of FOXP3 10000 40 5000 20 Hypomethylation Methylation Hypomethylation Methylation B C Hypomethylation Methylation FOXP3/β-ACTIN 2 4 8 6 Methylation 5 10 15 20 FOXP3/β-ACTIN Hypomethylation P=.01 3

Supplementary Figure S4 Isotype ATL cells A NS 15000 Hypomethylation Methylation 100 10000 MFI of CD25 Cell Numbers (% Max) 5000 MFI =5134 MFI =2163 CD25 Hypomethylation Methylation Regulatory T cells B NS 4000 Hypomethylation Methylation 100 3000 Cell Numbers (% Max) MFI of CTLA4 2000 MFI =914 MFI =1667 1000 CTLA4 Hypomethylation Methylation Regulatory T cells C NS Hypomethylation Methylation 800 100 600 MFI of GITR Cell Numbers (% Max) 400 MFI =391 MFI =345 200 GITR Hypomethylation Methylation Regulatory T cells D NS 15000 Hypomethylation Methylation 100 10000 MFI of CCR4 Cell Numbers (% Max) 5000 MFI =6482 MFI =4831 CCR4 Hypomethylation Methylation Regulatory T cells

Supplementary Figure S4 Isotype ATL cells NS E 4000 Hypomethylation Methylation 3000 100 MFI of HELIOS 2000 Cell Numbers (% Max) 1000 MFI =1286 MFI =1539 HELIOS Hypomethylation Methylation Regulatory T cells F NS 100 Hypomethylation Methylation 80 100 60 1.64% 63.4% % of Ki67+ cells Cell Numbers (% Max) 40 20 Ki67 Hypomethylation Methylation Regulatory T cells

Treg cells from healthy donor Supplementary Figure S5 Isotype ATL cells A NS 30 Hypomethylation Methylation CD4+ from healthy donor 100 20 0.70% 5.86% 16.0% % of IFN-γ+ cells Cell Numbers (% Max) 10 IFN-γ Hypomethylation Methylation B NS Methylation 30 Hypomethylation CD4+ from healthy donor 100 0.80% 11.3 % 2.32 % 20 % of IL-4+ cells Cell Numbers (% Max) 10 IL-4 Hypomethylation Methylation NS C 30 Hypomethylation Methylation CD4+ from healthy donor 100 20 0.26% 2.66 % 0.34 % % of IL-17+ cells Cell Numbers (% Max) 10 Hypomethylation Methylation IL-17 D NS Hypomethylation Methylation Treg cells from healthy donor 30 100 0.65% 10.8% 8.85% 20 Cell Numbers (% Max) % of IL-10+ cells 10 IL-10 Hypomethylation Methylation 6

Supplementary Figure S5 E NS Hypomethylation Methylation CD4+ from healthy donor 30 100 0.64% 3.89% 18.0% 20 Cell Numbers (% Max) % of IL-2+ cells 10 IL-2 Hypomethylation Methylation F NS Hypomethylation Methylation CD4+ from healthy donor 30 100 14.7% 0.28% 3.52% 20 Cell Numbers (% Max) % of TNF-α+ cells 10 TNF-α Hypomethylation Methylation 7

Supplementary Figure S6 NS P=0.02 120 80 CTLA4/β-ACTIN 40 Hypomethylation Methylation Regulatory T cells CD4+ conventional T cells B NS P=0.02 60 40 HELIOS/β-ACTIN 20 Hypomethylation Methylation Regulatory T cells CD4+ conventional T cells C NS P=0.009 120 80 EOS/β-ACTIN 40 Hypomethylation Methylation Regulatory T cells CD4+ conventional T cells

Supplementary Figure S7 Responder cells : ATL cells Responder alone 1:1 1:1 1:1 1:1 88.2% 40.0% 39.2% 71.3% 58.3% MJ ATL-43T MT-1 Hut102 * * * % of proliferative cells Responder alone MJ ATL-43T MT-1 Hut102 * * * Total numbers of responder cells Responder alone MJ ATL-43T MT-1 Hut102

A B Supplementary Figure S8 NS 8000 6000 1800 1600 500 tax / 18S rRNA 400 300 200 100 Hypomethylation Methylation Regulatory T cells CD4+ conventional T cells B NS 100 90 5 1 0.6 HBZ / 18S rRNA 0.4 0.2 Hypomethylation Methylation Regulatory T cells CD4+ conventional T cells

Supplementary Figure S9 1.0 Methylation Hypomethylation 0.8 P=.1 0.6 Overall survival 0.4 0.2 1000 2000 3000 4000 Days after diagnosis (days) B 1.0 CD45RA-FOXP3high > 20% 0.8 CD45RA-FOXP3high < 20% P=.14 0.6 Overall survival 0.4 0.2 1000 2000 3000 4000 Days after diagnosis (days) C 1.0 CD45RA-FOXP3high > 20% CD45RA-FOXP3high < 20% 0.8 P=.16 0.6 Overall survival 0.4 0.2 1000 2000 3000 4000 Days after diagnosis (days)

Supplementary Figure S10 Healthy donor Fr I: 2.3% Fr II: 6.2% Fr III: 5.1% FOXP3 CD45RA Case F1 Case F5 0.1% 56% 35% 0% 7% 92% Case F9 0% 2% 21% Case F13 0% 17% 7% 0.1% 1% Case F2 0% 0% 13% 4% Case F6 0% 44% 20% Case F10 Case F14 0.2% 31% 28% 0% 18% 79% Case F3 0% 92% 7% Case F7 0% 0.2% Case F11 Case F4 0% 35% 7% Case F8 0% 41% 29% Case F12 0% 32% 38%